Colloid vs Crystalloid Infusion Postoperative in CABG Patients Regarding Renal Hemodynamics and Function
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Change from baseline and differences inbetween groups in glomerular filtration rate, measured at different timepoints
研究概览
简要总结
Comparing the effects of crystalloid versus colloid fluid resuscitation in CABG patients postoperatively regarding renal blood flow, glomerular filtration rate and renal oxygen demand.
详细描述
Due to blood loss and SIRS postoperative hypovolemia is a usual feature after CABG surgery. Substantial controversy persists regarding the best choice of fluid to be used for resuscitation in this setting regarding renal function and oxygen supply-demand matching. In our study we aim to investigate differences in functional renal parameters by dividing patients postoperatively in two groups, substituted either with crystalloid fluid, Ringer-Acetat, 20 ml/kg or colloid, HES 6% (130/0,4) 10 ml/kg under 20 minutes. Central and renal hemodynamics will be measured before (baseline) and after fluid administration by blood sampling and thermodilution in both pulmonary artery catheter and renal vein catheter. Measurement endpoints will mainly consist of central hemodynamics, renal blood flow, GFR and renal oxygen extraction rate which we aim to compare between groups.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •elective fast track CABG patients, postoperative
排除标准
- •hemodynamic instability
- •preoperative renal impairment
- •major postoperative bleeding
研究组 & 干预措施
crystalloid
crystalloid fluid administration, Ringer-acetat 20ml/kg under 30 minutes
干预措施: crystalloid (Drug)
colloid
colloidal fluids administration, HES 6% (130/0,4) 7ml/kg under 30 minutes
干预措施: colloid (Drug)
结局指标
主要结局
Change from baseline and differences inbetween groups in glomerular filtration rate, measured at different timepoints
时间窗: 125min after baseline-measures
GFR measured by thermodilution and blood- and urine sampling baseline1 (0min), baseline2 (+30min), timepoint1 (+65min), tp2 (+85min), tp3 (+105min), tp4 (+125min)
次要结局
未报告次要终点
研究者
Jenny Skytte Larsson
MD
Sahlgrenska University Hospital, Sweden
